Agios Announces Key Anticipated 2024 Milestones Across Rare

Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio

Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , United States , American , Chris Taylor , Dan Budwick , Brian Goff , Exchange Commission , Agios Pharmaceuticals Inc , Nasdaq , American Society Of Hematology , Agios Pharmaceuticals , Business Development , Corporate Communications , Company Expects Four Additional Phase , Franchise Has Demonstrated Clinical Efficacy , Four Hematological Diseases , Including New Positive Phase , Non Transfusion Dependent Thalassemia , Sickle Cell Disease , Strong Cash Position Expected , Support Completion , Ongoing Programs , Disciplined Pipeline Expansion , Healthcare Conference , Cell Disease , Myelodysplastic Syndromes , Investigational New Drug Application , American Society , Annual Meeting , New Drug Application , Additional Phase , Two Potential New Indication Approvals Expected , Private Securities Litigation Reform Act ,